Safety and tolerability of long-term apomorphine infusion in advanced Parkinson's disease: an Indian multi-center (APO-IND) experience.
Saved in:
| Title: | Safety and tolerability of long-term apomorphine infusion in advanced Parkinson's disease: an Indian multi-center (APO-IND) experience. |
|---|---|
| Authors: | Metta V; Department of Neurosciences, Institute of Psychiatry, Psychology and Neuroscience and Parkinson's Foundation Centre of Excellence, King's College London, King's College Hospital, London, UK. vinod.metta@nhs.net.; Parkinson's Foundation Centre of Excellence, King's College Hospital, London, Dubai, United Arab Emirates. vinod.metta@nhs.net.; Parkinson's Foundation Centre of Excellence, King's College Hospital London, London, SE5 9RS, UK. vinod.metta@nhs.net., Dhamija RK; Institute of Human Behavior and Allied Sciences, Lady Hardinge Medical College and SSK Hospital, New Delhi, India., Batzu L; Department of Neurosciences, Institute of Psychiatry, Psychology and Neuroscience and Parkinson's Foundation Centre of Excellence, King's College London, King's College Hospital, London, UK.; Parkinson's Foundation Centre of Excellence, King's College Hospital, London, Dubai, United Arab Emirates., Mrudula R; Institute of Movement Disorders, Narayana Medical College and Postgraduate Research Centre, Nellore, India.; Nizams Institute of Medical Sciences, Hyderabad, Telangana, India., Kumar NSS; Institute of Movement Disorders, Narayana Medical College and Postgraduate Research Centre, Nellore, India., S A; SRM Institute of Medical Sciences and Technology, Chennai, India., Falup-Pecurariu C; Department of Neurology, Transilvania University of Brasov, Brasov, Romania., Rodriguez-Blazquez C; Carlos 111, Health Institute, Madrid, Spain., Goyal V; Institute of Movement Disorders and Parkinson's Centre, Medanta Hospital, New Delhi, India., L K P; Center for Parkinson's Disease and Movement Disorders, Manipal Hospital, Bangalore, India., Bhattacharya K; R G Kar Medical College and Hospital, Kolkata, India., Kumar S; Amrita Institute of Medical Sciences, Kochi, India., Chaudhuri KR; Department of Neurosciences, Institute of Psychiatry, Psychology and Neuroscience and Parkinson's Foundation Centre of Excellence, King's College London, King's College Hospital, London, UK.; Parkinson's Foundation Centre of Excellence, King's College Hospital, London, Dubai, United Arab Emirates., Borgohain R; Nizams Institute of Medical Sciences, Hyderabad, Telangana, India. |
| Source: | Scientific reports [Sci Rep] 2023 Oct 31; Vol. 13 (1), pp. 18681. Date of Electronic Publication: 2023 Oct 31. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2045-2322 |
|---|---|
| DOI: | 10.1038/s41598-023-46003-4 |
